diquafosol has been researched along with denufosol tetrasodium in 9 studies
| Studies (diquafosol) | Trials (diquafosol) | Recent Studies (post-2010) (diquafosol) | Studies (denufosol tetrasodium) | Trials (denufosol tetrasodium) | Recent Studies (post-2010) (denufosol tetrasodium) |
|---|---|---|---|---|---|
| 126 | 38 | 92 | 6 | 0 | 0 |
| 126 | 38 | 92 | 26 | 6 | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dougherty, RW; Douglass, JG; Pendergast, W; Redick, CC; Rideout, JL; Shaver, SR; Sims, IF; Yerxa, BR | 1 |
| Besada, P; Calenbergh, SV; Costanzi, S; Cosyn, L; Fricks, I; Harden, TK; Ivanov, AA; Jacobson, KA; Ko, H; Maddileti, S | 1 |
| Besada, P; Cappellacci, L; Carter, RL; Cosyn, L; de Castro, S; Franchetti, P; Grifantini, M; Harden, TK; Jacobson, KA; Ko, H; Petrelli, R; Van Calenbergh, S; Zhou, Y | 1 |
| Fischer, B; Ginsburg-Shmuel, T; Haas, M; Kalid, O; Reiser, G; Schumann, M; Stern, N | 1 |
| Abraham, WM; Boucher, RC; Boyer, J; Cowlen, M; Davis, CW; Dougherty, R; Jones, AC; Lang-Furr, M; Picher, M; Sabater, JR; Stutts, MJ; Yerxa, BR | 1 |
| Evans, R; Kellerman, D; Mathews, D; Shaffer, C | 1 |
| Amar, T; Caillaud, T; Douglass, JG; Edick, C; Elena, PP; Peterson, WM; Yerxa, BR | 1 |
| Engels, J; Gorden, J; Kellerman, D; Rossi Mospan, A; Schaberg, A; Smiley, L | 1 |
| Appy, L; Chardet, C; Peyrottes, S; Roy, B | 1 |
3 review(s) available for diquafosol and denufosol tetrasodium
| Article | Year |
|---|---|
Inhaled P2Y2 receptor agonists as a treatment for patients with Cystic Fibrosis lung disease.
Topics: Administration, Inhalation; Animals; Clinical Trials as Topic; Cystic Fibrosis; Deoxycytosine Nucleotides; Epithelium; Humans; Mucociliary Clearance; Ophthalmic Solutions; Polyphosphates; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2Y2; Uracil Nucleotides; Uridine | 2002 |
Denufosol: a review of studies with inhaled P2Y(2) agonists that led to Phase 3.
Topics: Administration, Inhalation; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cystic Fibrosis; Deoxycytosine Nucleotides; Female; Forced Expiratory Volume; Humans; Male; Polyphosphates; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2Y2; Uracil Nucleotides; Uridine | 2008 |
Synthetic Strategies for Dinucleotides Synthesis.
Topics: Deoxycytosine Nucleotides; Dinucleoside Phosphates; Dry Eye Syndromes; Green Chemistry Technology; Humans; Ophthalmic Solutions; Phosphorylation; Polyphosphates; Purinergic P2Y Receptor Agonists; Receptors, Purinergic; Uracil Nucleotides; Uridine | 2019 |
6 other study(ies) available for diquafosol and denufosol tetrasodium
| Article | Year |
|---|---|
Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates.
Topics: Calcium; Dinucleoside Phosphates; Humans; Protein Binding; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Spectrometry, Fluorescence; Structure-Activity Relationship; Transduction, Genetic; Tumor Cells, Cultured; Uracil Nucleotides | 2001 |
Molecular modeling of the human P2Y2 receptor and design of a selective agonist, 2'-amino-2'-deoxy-2-thiouridine 5'-triphosphate.
Topics: Adenosine Triphosphate; Binding Sites; Cell Line, Tumor; Drug Design; Humans; Models, Molecular; Monte Carlo Method; Protein Conformation; Purinergic P2 Receptor Agonists; Quantitative Structure-Activity Relationship; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Uridine Triphosphate | 2007 |
Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists.
Topics: Humans; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Structure-Activity Relationship; Uracil Nucleotides | 2008 |
5-OMe-UDP is a potent and selective P2Y(6)-receptor agonist.
Topics: Calcium; Cell Line, Tumor; Humans; Ligands; Magnetic Resonance Spectroscopy; Molecular Conformation; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Structure-Activity Relationship; Transfection; Uridine Diphosphate | 2010 |
Pharmacology of INS37217 [P(1)-(uridine 5')-P(4)- (2'-deoxycytidine 5')tetraphosphate, tetrasodium salt], a next-generation P2Y(2) receptor agonist for the treatment of cystic fibrosis.
Topics: Animals; Astrocytoma; Brain Neoplasms; Calcium; Chlorides; Cilia; Cystic Fibrosis; Deoxycytosine Nucleotides; Epithelial Cells; Humans; In Situ Hybridization; In Vitro Techniques; Indicators and Reagents; Macaca mulatta; Mucins; Mucociliary Clearance; Ophthalmic Solutions; Polyphosphates; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Reverse Transcriptase Polymerase Chain Reaction; Sheep; Tumor Cells, Cultured; Uracil Nucleotides; Uridine | 2002 |
Potency and duration of action of synthetic P2Y2 receptor agonists on Schirmer scores in rabbits.
Topics: Animals; Deoxycytosine Nucleotides; Eye; Male; Ophthalmic Solutions; Polyphosphates; Purinergic P2 Receptor Agonists; Rabbits; Tears; Uracil Nucleotides; Uridine | 2002 |